Enhancing mental capacity. Dr Sarah JL Edwards Senior Lecturer in Research Governance
|
|
|
- Marion Ellis
- 6 years ago
- Views:
Transcription
1 Enhancing mental capacity Dr Sarah JL Edwards Senior Lecturer in Research Governance
2 Contents Patients understanding medical information Assessing mental capacity Treating those without capacity Informational manipulation
3 Patients understanding cancer screening the 5-year survival of patients diagnosed with early stage cancers is much greater than that of patients diagnosed with later stage cancers (Schwartz 1999, p.128). People usually believe that this shows screening is beneficial, but patients diagnosed earlier live with a cancer diagnosis longer.
4 Understanding Risk Grimes and Snively (1999) asked 633 women in a gynaecology outpatient s clinic to compare which of the risk levels represented by 8.9 per 1000 and 2.6 per 1000 was the higher Risks stated as rates were better understood than as proportions (Lloyd 2001, p.i16)
5 Goal of treatment Gattellari et al. (2002) reported that 80% of patients who had been told by their physician that there was no chance of cure stated that there was actually some chance of cure, while 15% stated that their chance of cure was at least 75%.
6 Assessing Capacity A person lacks capacity in relation to a matter if at the material time he is unable to make a decision for himself in relation to the matter because of an impairment of, or a disturbance in the functioning of, the mind or brain. s2(1)
7 In practice Assume patient has various degrees of ability along certain dimension that can be measured Expert judgement/impression Neurological predictive factors 18 different objective instruments Constructs have different meanings First- or third-person scenarios
8 The Mini-Mental State Exam Patient Examiner Date Maximum Score Orientation 5 ( ) What is the (year) (season) (date) (day) (month)? 5 ( ) Where are we (state) (country) (town) (hospital) (floor)? Registration 3 ( ) Name 3 objects: 1 second to say each. Then ask the patient all 3 after you have said them. Give 1 point for each correct answer. Then repeat them until he/she learns all 3. Count trials and record. Trials Attention and Calculation 5 ( ) Serial 7 s. 1 point for each correct answer. Stop after 5 answers. Alternatively spell world backward. Recall 3 ( ) Ask for the 3 objects repeated above. Give 1 point for each correct answer. Language 2 ( ) Name a pencil and watch. 1 ( ) Repeat the following No ifs, ands, or buts 3 ( ) Follow a 3-stage command: Take a paper in your hand, fold it in half, and put it on the floor. 1 ( ) Read and obey the following: CLOSE YOUR EYES 1 ( ) Write a sentence. 1 ( ) Copy the design shown. Total Score ASSESS level of consciousness along a continuum Alert Drowsy Stupor Coma
9 McArthur competence tool Semi-structured interview In conjunction with clinical assessment Measure on scale 0-6 understanding of the disorder and its treatment, including associated risks and benefits Appreciation of the disorder and its treatment (belief) Ability to compare treatment with alternatives Ability to express a choice TRAT fictional vignettes Grisso and Appelbaum Am J Psychiatry 1995; 152:
10 Re C (1994) 1 All ER 819 Case Law Schizophrenic refusing amputation for gangrenous leg Believed he was world class surgeon Court ruled he was competent to decide Not treated under Mental Health Act for his schizophrenia!
11 Statue s3(1) A person is unable to make a decision for himself if he is unable to: 1)understand the information relevant to the decision; 2)retain the information; 3)use or weigh that in formation as part of the process of making the decision; or 4)communicate his decision (whether by talking, using sign language or any other means).
12 Still no belief requirement No express requirement in test that person believes the information or has insight into illness If false belief results from psychotic delusion then assessed formally under mental health legislation Denial of the facts itself not sufficient to render incapable (remember Jo and denial of his daughter s death?)
13 Marginal or fluctuating capacity Protect person s position in event s/he is likely to regain capacity New right to have all practical help New role for statutory Independent Mental Capacity Advocate service (IMCA) May be duty to provide specialist help outside normal fiscal restraints
14 The decision-maker should make sure that all practical means are used to enable and encourage the person to participate as fully as possible in the decision-making process and any action taken as a result, or to help the person improve their ability to participate.
15 Help to restore capacity The explanation must be in the most appropriate and effective form of communication for that person. There are different methods for people who use nonverbal means of communication (for example, observing behaviour or their ability to recognise objects or pictures).
16 Use of equipment? It may be important to provide access to technology. For example, some people who appear not to communicate well verbally can do so very well using computers.
17 MCA Code of Practice chapt 3 using simple language and/or illustrations or photographs asking them about the decision at a time and location where the person feels most relaxed and at ease breaking the information down into easyto-understand points using specialist interpreters or signers to communicate with the person.
18 Yes/No Avoid questions that need only a yes or no answer (for example, did you understand what I just said?)...but there may be no alternative in cases where there are major communication difficulties. In these cases, check the response by asking questions again in a different way.
19 Treating non-competent adults: best interests Decisions made under the MCA must be made in the person s best interests Sole exception is in event of valid and applicable advance decision/statement Competent person may nominate another (donee of Lasting Power of Attorney) to make decisions in case of incompetence
20 Common law doctrine of necessity Act in best interests of non-competent patient but treatment must be necessary Protect doctor from liability for acts which could otherwise amount to battery Re F (Mental Patient: Sterilisation) [1990] 2 AC 1
21 Assessing best interests New statutory criterion s4 Consider person s past and present wishes and feelings (particularly any advance statements) Consider beliefs and values that would be likely to influence his decision if he had capacity Consider the other factors that he would be likely to consider if he were able to do so Not complete checklist No order of priority given But assessment must be reasonable in the circumstances
22 Process of Consultation When practical and appropriate, decisionmaker must also consult following people as to what would be in person s best interests Anyone named by person Anyone engaged in caring for person or interested in his welfare Any donee of a lasting power of attorney Any deputy appointed for person by Court Code of practice encourages as wide a range of people who are close to the person except in research where single consultee
23 Persuasion paradox Patient unaware that information has been manipulated which could itself undermine autonomy
24 Framing risk Schwartz (1999) simple changes in the format of otherwise identical numerical information can profoundly influence its interpretation (p. 127). Given a choice between surgery and radiotherapy, patients would tend to choose surgery despite probable outcomes being the same but framed differently:
25 Whose interests? Manipulating information truly in patient s best interests? Hard vs soft paternalism Fairness and statistics Evaluating effects
Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005
Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 April 2015 Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 The RMBI,
MENTAL CAPACITY ACT POLICY (England & Wales)
Stalbridge Surgery Reviewed June 2017 Next review date June 2018 INTRODUCTION MENTAL CAPACITY ACT POLICY (England & Wales) The Mental Capacity Act (MCA) 2005 became fully effective on 1 st October 2007
!This booklet is for family and friends of anyone who.!these decisions may be related to treatment they re
MENTAL CAPACITY ACT INFORMATION What is the Mental Capacity Act? The Mental Capacity Act 2005 (MCA) was implemented by parliament in 2007 and is a vitally important piece of legislation for England and
Unit 5 MCA & DOLS. Deprivation of Liberty Safeguards (DOLS) Lasting Powers of Attorneys (LPAs) Advance Decisions to Refuse Treatment (ADRTs)
Unit 5 MCA & DOLS Unit 5 MCA & DOLS INTRODUCTION The Mental Capacity Act 2005 covering England and Wales provides a statutory framework for people who lack capacity to make decisions for themselves, or
MINI-MENTAL STATE EXA MINATION (M MSE)
MINI-MENTAL STATE EXA MINATION (M MSE) M axim u m Score Score 5 5 Orientation What is the (day of week) (day of month) (month) (year) (season)? Where are we: (state) (county) (town) (facility) (floor)?
4. Adults Lacking Capacity to Consent to Research
4. Adults Lacking Capacity to Consent to Research Introduction There are different laws in each UK country for research that involves adults who lack the capacity to consent to research; the correct law
the general hospital: case discussions
Assessing capacity in the general hospital: case discussions Jim Bolton Consultant t Liaison i Psychiatrist i t St Helier Hospital, London Introduction Different jurisdictions MCA & MHA Case examples to
Assessment of Mental Capacity and Best Interest Decisions
Standard Operating Procedure 1 (SOP 1) Assessment of Mental Capacity and Best Interest Decisions Why we have a procedure? This Standard Operating Procedure (SOP) is required to set out how a person s capacity
Mental capacity and mental illness
Mental capacity and mental illness The Mental Capacity Act 2005 (MCA) Mental capacity is the ability to make your own decisions. If you lose mental capacity the Mental Capacity Act 2005 (MCA) protects
MINI MENTAL STATE EXAM
MINI MENTAL STATE EXAM ID NUMBER: FORM CODE: M M E DATE: 06/01/2011 Version 2.0 ADMINISTRATIVE INFORMATION 0a. Completion Date: / / 0b. Staff ID: Month Day Year Materials: Black pen, pencil, wrist watch,
CENTRES 8 th International Clinical Ethics Conference Mental Health - Challenges in Clinical Ethics
CENTRES 8 th International Clinical Ethics Conference Mental Health - Challenges in Clinical Ethics Primer 1: Mental Capacity Assessments for Treatment Date: 30 th October 2018 Venue: NUSS Kent Ridge Guild
The Mental Capacity Act 2006 and the management of challenging behaviours: Applications to the Northern Ireland Capacity Bill
The Mental Capacity Act 2006 and the management of challenging behaviours: Applications to the Northern Ireland Capacity Bill Andrew McDonnell, Director, Studio3 Training Systems, www.studio3.org The Mental
FACTORS AFFECTING CAPACITY
FACTORS AFFECTING CAPACITY Psychosocial Factors Affecting Capacity Psychosocial factors include one s surroundings, way of life & things that affect relationships between the adult and their environment.
What happens if I cannot make decisions about my care and treatment?
Information Line: 0800 999 2434 Website: compassionindying.org.uk What happens if I cannot make decisions about my care and treatment? This factsheet explains how decisions are made about your care or
Advance Statements. What is an Advance Statement? Information Line: Website: compassionindying.org.uk
Information Line: 0800 999 2434 Website: compassionindying.org.uk This factsheet explains what an Advance Statement is and how to make one. It is for people living in England and Wales. If you live in
Mental capacity and the Mental Capacity Act 2005
Mental capacity and the Mental Capacity Act 2005 Introduction Although the Mental Capacity Act (MCA) has implications for other aspects of PWS, this article will focus on the possible relevance of the
Discussion. Re C (An Adult) 1994
Autonomy is an important ethical and legal principle. Respect for autonomy is especially important in a hospital setting. A patient is in an inherently vulnerable position; he or she is part of a big and
Planning for a time when you cannot make decisions for yourself
Planning for a time when you cannot make decisions for yourself An information leaflet for members of the public Version: October 2013 Introduction The Mental Capacity Act 2005 allows you to plan ahead
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID. Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID Patient s surname/family name Patient s first names Date of birth NHS number (or other identifier)
ECT and the law. Dr Hugh Series. Consultant old age psychiatrist, Oxford Health NHS FT Member, Law Faculty, University of Oxford
ECT and the law Dr Hugh Series Consultant old age psychiatrist, Oxford Health NHS FT Member, Law Faculty, University of Oxford Outline Assault Mental health law in E&W MHA ECT in general hospital MCA DOLS
Making Sense of Mental Capacity. The right to decide... And deciding right
Making Sense of Mental Capacity The right to decide... And deciding right The Mental Capacity Act 2005 Who must follow the Act and Code of Practice? Everyone working or for those who may lack capacity
Mental Capacity Implementation Programme. Mental Capacity Act 2005
Mental Capacity Implementation Programme Mental Capacity Act 2005 The Presentation Is an Overview and Will Cover: Part one - background and key policy Why we needed the act and who it affects The Mental
The Mental Capacity Act 2007 and capacity assessments: a guide for the non-psychiatrist
PROFESSIONAL ISSUES The Mental Capacity Act 2007 and capacity assessments: a guide for the non-psychiatrist Elora Mukherjee and Russell Foster ABSTRACT The Mental Capacity Act 2007 affects doctors in all
Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB. Patient s first names.
Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine- Carboplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Pembrolizumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Atezolizumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB. Patient s first names. Date of birth.
Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Carboplatin-Etoposide PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL
Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL Patient s surname/family name Patient s first names Date of birth
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-EC PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Dabrafenib-Trametinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Irinotecan- Capecitabine (CAPIRI) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
Learner Workbook Awareness of the Mental Capacity Act 2005 (MCA01) Level 3
Learner Workbook Awareness of the Mental Capacity Act 2005 (MCA01) Level 3 C T D [ T y p e t h e c o m p a n y a d d r e s s ] [ T y p e t h e p h o n e n u m b e r ] [ T y p e t h e f a x n u m b e r
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Zoledronic acid PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS Patient s surname/family name Patient s first names Date of birth Hospital
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: FEC-P PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP: MALE
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE)
Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Everolimus PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Conducting Research in Those with Cognitive Impairments 101
Conducting Research in Those with Cognitive Impairments 101 Kevin Duff, PhD Department of Neurology Center for Alzheimer s Care, Imaging, & Research University of Utah 11/8/12 Center for Alzheimer s Care,
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Axitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: BEP (5 day) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Cognitive Assessment. Part Two: Assessing Capacity, Beyond The Basics. Using Information To Make Decisions (Appreciating) What s s The Correct Method?
AUTONOMY, CAPACITY AND UNDUE INFLUENCE: KEMP Page 1 of 9 Part Two: Assessing Capacity, Beyond The Basics Cognitive Assessment Bryan Kemp, Ph. D. Center of Excellence in Elder Abuse and Neglect UC Irvine
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Oxaliplatin- Fluorouracil (FOLFOX) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Niraparib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Pazopanib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
Mental Capacity Act 2005 Competency Toolkit
Mental Capacity Act 2005 Competency Toolkit The MCA is a law that affects all of us. Anyone in any position where interaction with the public is a part of their role will need to have a basic awareness
MENTAL STATE EXAMINATION FAHAD ALOSAIMI MBBS, SSC- PSYCH CONSULTATION LIAISON PSYCHIATRIST KING SAUD UNIVERSITY
MENTAL STATE EXAMINATION FAHAD ALOSAIMI MBBS, SSC- PSYCH CONSULTATION LIAISON PSYCHIATRIST KING SAUD UNIVERSITY The mental status examination( MSE) MSE is a cross-sectional, systemic documentation of the
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cisplatin- Capecitabine- Trastuzumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth
Page 1 of 6 FORM FERRERI / IELSG PROTOCOL Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-Oxaliplatin- Fluorouracil (FLOT) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Nintedanib-Docetaxel PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
Shropshire Multi-Agency Mental Capacity Act Guidance September 2015 Page 1
Policies, Procedures, Guidelines and Protocols Document Details Title Mental Capacity Act (MCA) multi-agency guidance Trust Ref No 1710-30681 Local Ref (optional) Main points the document MCA Guidance
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Bevacizumab + Chemotherapy PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB. Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital
Overview of neurological changes in Alzheimer s disease. Eric Karran
Overview of neurological changes in Alzheimer s disease Eric Karran Alzheimer s disease Alois Alzheimer 1864-1915 Auguste D. 1850-1906 Case presented November 26 th 1906 Guildford Talk.ppt 20 th March,
Who Decides? Understanding the Mental Capacity Act 2005 CDC Conference January 2017 Daisy Russell
Who Decides? Understanding the Mental Capacity Act 2005 CDC Conference January 2017 Daisy Russell Mental Capacity Act 2005 Applies to everyone over the age of 16 It sets out what should happen when people
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names.
Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Sunitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
DoLS Code of Practice para 4.33 The purpose of the mental health assessment is to establish whether the relevant person is suffering from a mental dis
Deprivation of Liberty Safeguards (DoLS) Module 2: Slides 2 Mental Health, Mental Capacity, Eligibility ibilit Assessments DoLS Code of Practice para 4.33 The purpose of the mental health assessment is
Mental Capacity Act 2005
Mental Capacity Act 2005 Factsheet 460LP October 2015 People with dementia often become unable to make some decisions for themselves as their condition progresses. When this happens, the person is said
Competence, consent and Coercion: A medico-legal conundrum. Dr Rees Tapsell Ms Meenal Duggal
Competence, consent and Coercion: A medico-legal conundrum Dr Rees Tapsell Ms Meenal Duggal Overview Clinical Context Consultation Liaiosn services within a general hospital Legal commentry Clinical Scenario
Self-directed support
Self-directed support The Mental Capacity Act 2005 This gives a brief introduction to the Mental Capacity Act 2005. The Mental Capacity Act contains a lot of information and this gives a very general overview
Winter Night Shelters and Mental Healh Barney Wells, Enabling Assessment Service London.
Winter Night Shelters and Mental Healh Barney Wells, Enabling Assessment Service London. Introduction goals of session - What is mental health - What is interaction between poor mental health and CWS -
The Language, Ethics & Law of Self-Determination
Decision Making Capacity: Implications for Advance Care Planning Facilitators Linda Briggs, MS, MA, RN Senior Faculty Consultant & Ethics Consultant, Respecting Choices Gundersen Health System La Crosse,
Money management for people who may lack capacity. Alison Picton
Money management for people who may lack capacity Alison Picton Overview what the Mental Capacity Act (MCA) says about decision making what decisions can a person make about their money? if a person can
Trafford Capacity Assessment & Best Interests Pack
Trafford Capacity Assessment & Best Interests Pack June 2016 Contents of the Pack Capacity Assessment Guidance Capacity Assessment Document Generic Best Interest Decision Form DNAR Best Interest Decision
Seeking Consent: Working with People in Prison
Seeking Consent: Working with People in Prison Seeking Consent: Working with People in Prison This booklet has been developed with advice from the Department of Health s Good practice in consent Advisory
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Ponatinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
ASSESSMENT OF DECISION MAKING CAPACITY IN ADULTS PARTICIPATING IN A RESEARCH STUDY 6/8/2011
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program ASSESSMENT OF DECISION MAKING CAPACITY IN ADULTS PARTICIPATING IN A RESEARCH STUDY 6/8/2011 As a general rule, all adults, regardless of
Supporting people with dementia using the MCA
Supporting people with dementia using the MCA SCIE-funded resource Alzheimer s Society and Jackie Pool Associates Acknowledgements Alzheimer s Society and Jackie Pool Associates would like to thank SCIE
A mental health power of attorney allows you to designate someone else, called an agent, to
What is a Mental Health Advance Directive? A Mental Health Advanced Directive is a document that allows you to make your choices known, regarding mental health treatment, in the event that your mental
Autism Action Network Charter
Autism Action Network Charter Introduction The Autism Action Network is an exciting opportunity for you to be part of a passionate community committed to helping people with autism to live the life they
Janet Grace Consultant Psychiatrist Kerry Graham Acting MH Legislation Development Lead. Rajesh Nadkarni Acting Executive Medical Director
Practice Guidance Note Mental Capacity Act - Assessing Capacity for Consent to Sexual Relations V02 Date issued Issue 1 Feb 16 Planned review February 2019 MCA-PGN-01 Part of NTW(C)34 MCA Policy Author/Designation
Decision-Making Capacity
Decision-Making Capacity At the end of the session, participants will be able to: Know the definition of decision-making capacity; Understand the distinction between decision-making capacity and competency;
Research with Vulnerable Participants
Research with Vulnerable Participants The views expressed in this talk are my own. They do not represent the position or policy of the NIH, DHHS, or U.S. government Non-beneficial Interventions Clinical
MENTAL HEALTH ADVANCE DIRECTIVE
Mental Health Association in Pennsylvania 2005 Instructions and Forms MENTAL HEALTH ADVANCE DIRECTIVES FOR PENNSYLVANIANS MENTAL HEALTH ADVANCE DIRECTIVE I,, have executed an advance directive specifying
Liberty, Coercion, and Mental Health Treatment
Liberty, Coercion, and Mental Health Treatment Paul S. Appelbaum, MD Dollard Professor of Psychiatry, Medicine, and Law Columbia University/NY State Psychiatric Institute History of MH Treatment in US
Specialist Research Ethics Guidance Paper RESEARCH INVOLVING ADULT PARTICIPANTS WHO LACK THE CAPACITY TO CONSENT
Specialist Research Ethics Guidance Paper RESEARCH INVOLVING ADULT PARTICIPANTS WHO LACK THE CAPACITY TO CONSENT This note covers all research undertaken at the University that involves the recruitment
Legal and Ethical Issues for Medical Students. Dr Robyn McGregor Rozelle Hospital and Dr. Bob Russell R.N.S.H.
Legal and Ethical Issues for Medical Students Dr Robyn McGregor Rozelle Hospital and Dr. Bob Russell R.N.S.H. CAPACITY TO DECIDE WHAT IS CAPACITY? Capacity, or competence, is the ability to make a particular
Serious medical decisions regarding people in vegetative or minimally conscious states
Serious medical decisions regarding people in vegetative or minimally conscious states The role of family and friends Chronic Disorders of Consciousness Cardiff-York research centre 1 December 2013 The
FREQUENTLY ASKED QUESTIONS ABOUT MENTAL HEALTH ADVANCE DIRECTIVES GUIDE FOR CONSUMERS
(800) 692-7443 (Voice) (877) 375-7139 (TDD) www.disabilityrightspa.org FREQUENTLY ASKED QUESTIONS ABOUT MENTAL HEALTH ADVANCE DIRECTIVES GUIDE FOR CONSUMERS What is a Mental Health Advance Directive? A
Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families
Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families Overview If you had asked doctors about ALS 15 years ago, the majority of providers would have told you that ALS
GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS
GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS The purpose of this guidance document The purpose of this guidance is to explain what happens if you are asked by the General Optical
Good Practice Guidance on Covert Administration of Medication
Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their
Name at birth. Address. MMSE: CASE: Cognigram. MMSE (Folstein and coll., 1975) Temporal Orientation Day: Date: Month: Season: Year: /5
CASE Cognitive Assessment Scale for the Elderly Daniel Geneau - Daniel Taillefer Institution Examiner Date of exam Age Education Date of birth Room File No y m d Name at birth Usual name or spouse name
Making medical decisions
Making medical decisions Summary information for family and friends Making medical decisions when someone is in a vegetative or minimally conscious state This information sheet is for the family and close
Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013
Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013 1 MoCA 2 Overview of the MoCA Takes approximately 15 minutes to administer Requires
Decision-Making Capacity and Consent
Decision-Making Capacity and Consent Achieving Excellence in DoD HRPP: Taking an Active Role 27 June 2008 Marianne M. Elliott, MS, CIP Department of the Navy Human Research Protection Program Alion Science
DIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM
(800) 692-7443 (Voice) (877) 375-7139 (TDD) www.disabilityrightspa.org DIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM 1. Read each section very carefully. 2. You will be
COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E
COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S
Assessment of Decision-Making Capacity
Assessment of Decision-Making Capacity James Tew, Jr., MD Associate Professor, Department of Psychiatry University of Pittsburgh School of Medicine Associate Chief of Clinical Services Western Psychiatric
A practical guide to capacity assessment and patient consent in Hong Kong
JG Wong P Scully MEDICAL PRACTICE A practical guide to capacity assessment and patient consent in Hong Kong!"#$%&'()*+,-./012 A person s decision-making capacity is pivotal when a doctor determines whether
BASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 2 Motivating clients for treatment and addressing resistance Basic counselling skills for drug dependence treatment Special considerations when
Factsheet 72 Advance decisions, advance statements and living wills
Factsheet 72 Advance decisions, advance statements and living wills April 2018 About this factsheet There are things you can do to make sure others know which medical treatment(s) you would want to refuse